Back
Cue Biopharma Vs. GlycoMimetics Industry Stock Comparison
Buy
54
CUE
Cue Biopharma
Last Price:
1.51
Seasonality Move:
5.19%
Buy
68
GLYC
GlycoMimetics
Last Price:
0.41
Seasonality Move:
49.38%
Buy
54
Cue Biopharma (CUE)
is a Buy
Is Cue Biopharma a Buy, Sell or Hold?
- The current Cue Biopharma [CUE] share price is $1.50. The Score for CUE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- CUE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
GlycoMimetics (GLYC)
is a Buy
Is GlycoMimetics a Buy, Sell or Hold?
- The current GlycoMimetics [GLYC] share price is $0.40. The Score for GLYC is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- GLYC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CUE Stock Price Chart
What is Cue Biopharma's stock price today?
-
The Cue Biopharma share price today is $1.50
The current trend is moderately bearish and CUE is experiencing slight selling pressure.
GLYC Stock Price Chart
What is GlycoMimetics's stock price today?
-
The GlycoMimetics share price today is $0.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLYC is experiencing buying pressure, which is a positive indicator for future bullish movement.
CUE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 50.94 | Buy |
Chaikin Money Flow: | -441294 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.31 - 1.75) | Sell |
Bollinger Bands (100): | (0.58 - 1.36) | Buy |
GLYC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 64.59 | Buy |
Chaikin Money Flow: | 249808 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.16 - 0.42) | Buy |
Bollinger Bands (100): | (0.14 - 0.32) | Buy |
CUE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.68 | Sell |
20-day SMA: | 1.62 | Sell |
50-day SMA: | 1.12 | Buy |
200-day SMA: | 1.41 | Buy |
8-day EMA: | 1.62 | Sell |
20-day EMA: | 1.54 | Sell |
50-day EMA: | 1.29 | Buy |
200-day EMA: | 1.47 | Buy |
GLYC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.4 | Sell |
20-day SMA: | 0.33 | Buy |
50-day SMA: | 0.23 | Buy |
200-day SMA: | 1.04 | Sell |
8-day EMA: | 0.4 | Buy |
20-day EMA: | 0.34 | Buy |
50-day EMA: | 0.28 | Buy |
200-day EMA: | 0.76 | Sell |
Cue Biopharma Earnings Growth & CUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and an increase next year of $0.07 per share.
GlycoMimetics Earnings Growth & GLYC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.
Cue Biopharma Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
GlycoMimetics Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |